N,N'-desoxycarbadox: metabolite of carbadox [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 9568819 |
SCHEMBL ID | 10596267 |
MeSH ID | M0128285 |
Synonym |
---|
(2-quinoxalinylmethylene)hydrazinecarboxylic acid methyl ester |
n,n'-desoxycarbadox |
carbadox, deoxy- |
hydrazinecarboxylic acid, (2-quinoxalinylmethylene)-, methyl ester |
brn 0799004 |
desoxycarbadox |
xu4n6mkp8r , |
unii-xu4n6mkp8r |
55456-55-8 |
5-24-03-00423 (beilstein handbook reference) |
n,n'-deoxycarbadox |
SCHEMBL10596267 |
methyl 3-(2-quinoxalinylmethylene) carbazate |
desoxycarbadox, vetranal(tm), analytical standard |
1448350-02-4 |
methyl n-[(e)-quinoxalin-2-ylmethylideneamino]carbamate |
CS-0129350 |
HY-136428 |
hydrazinecarboxylic acid, 2-(2-quinoxalinylmethylene)-, methyl ester |
AKOS040758193 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.66) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |